Amikacin liposome inhalation suspension clinical benefit–risk assessment for refractory Mycobacterium avium complex lung disease
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Respiratory Society
2022-07-01
|
| Series: | ERJ Open Research |
| Online Access: | http://openres.ersjournals.com/content/8/3/00623-2021.full |
| _version_ | 1797809460461174784 |
|---|---|
| author | Theodore K. Marras Mariam Hassan Kevin C. Mange Monika Ciesielska Shilpa Dhar Murthy Zhanna Jumadilova Anjan Chatterjee |
| author_facet | Theodore K. Marras Mariam Hassan Kevin C. Mange Monika Ciesielska Shilpa Dhar Murthy Zhanna Jumadilova Anjan Chatterjee |
| author_sort | Theodore K. Marras |
| collection | DOAJ |
| first_indexed | 2024-03-13T06:53:08Z |
| format | Article |
| id | doaj.art-cbc83b69f5b94fd3a566773c04c2a933 |
| institution | Directory Open Access Journal |
| issn | 2312-0541 |
| language | English |
| last_indexed | 2024-03-13T06:53:08Z |
| publishDate | 2022-07-01 |
| publisher | European Respiratory Society |
| record_format | Article |
| series | ERJ Open Research |
| spelling | doaj.art-cbc83b69f5b94fd3a566773c04c2a9332023-06-07T13:30:19ZengEuropean Respiratory SocietyERJ Open Research2312-05412022-07-018310.1183/23120541.00623-202100623-2021Amikacin liposome inhalation suspension clinical benefit–risk assessment for refractory Mycobacterium avium complex lung diseaseTheodore K. Marras0Mariam Hassan1Kevin C. Mange2Monika Ciesielska3Shilpa Dhar Murthy4Zhanna Jumadilova5Anjan Chatterjee6 Dept of Medicine, University of Toronto and Toronto Western Hospital, Toronto, ON, Canada Insmed Incorporated, Bridgewater, NJ, USA Insmed Incorporated, Bridgewater, NJ, USA Insmed Incorporated, Bridgewater, NJ, USA Insmed Incorporated, Bridgewater, NJ, USA Insmed Incorporated, Bridgewater, NJ, USA Insmed Incorporated, Bridgewater, NJ, USA http://openres.ersjournals.com/content/8/3/00623-2021.full |
| spellingShingle | Theodore K. Marras Mariam Hassan Kevin C. Mange Monika Ciesielska Shilpa Dhar Murthy Zhanna Jumadilova Anjan Chatterjee Amikacin liposome inhalation suspension clinical benefit–risk assessment for refractory Mycobacterium avium complex lung disease ERJ Open Research |
| title | Amikacin liposome inhalation suspension clinical benefit–risk assessment for refractory Mycobacterium avium complex lung disease |
| title_full | Amikacin liposome inhalation suspension clinical benefit–risk assessment for refractory Mycobacterium avium complex lung disease |
| title_fullStr | Amikacin liposome inhalation suspension clinical benefit–risk assessment for refractory Mycobacterium avium complex lung disease |
| title_full_unstemmed | Amikacin liposome inhalation suspension clinical benefit–risk assessment for refractory Mycobacterium avium complex lung disease |
| title_short | Amikacin liposome inhalation suspension clinical benefit–risk assessment for refractory Mycobacterium avium complex lung disease |
| title_sort | amikacin liposome inhalation suspension clinical benefit risk assessment for refractory mycobacterium avium complex lung disease |
| url | http://openres.ersjournals.com/content/8/3/00623-2021.full |
| work_keys_str_mv | AT theodorekmarras amikacinliposomeinhalationsuspensionclinicalbenefitriskassessmentforrefractorymycobacteriumaviumcomplexlungdisease AT mariamhassan amikacinliposomeinhalationsuspensionclinicalbenefitriskassessmentforrefractorymycobacteriumaviumcomplexlungdisease AT kevincmange amikacinliposomeinhalationsuspensionclinicalbenefitriskassessmentforrefractorymycobacteriumaviumcomplexlungdisease AT monikaciesielska amikacinliposomeinhalationsuspensionclinicalbenefitriskassessmentforrefractorymycobacteriumaviumcomplexlungdisease AT shilpadharmurthy amikacinliposomeinhalationsuspensionclinicalbenefitriskassessmentforrefractorymycobacteriumaviumcomplexlungdisease AT zhannajumadilova amikacinliposomeinhalationsuspensionclinicalbenefitriskassessmentforrefractorymycobacteriumaviumcomplexlungdisease AT anjanchatterjee amikacinliposomeinhalationsuspensionclinicalbenefitriskassessmentforrefractorymycobacteriumaviumcomplexlungdisease |